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The mammalian Sonic hedgehog (Shh) signalling pathway is essential for embryonic development and the
patterning of multiple organs. Disruption or activation of Shh signalling leads to multiple birth defects,
including holoprosencephaly, neural tube defects and polydactyly, and in adults results in tumours of the
skin or central nervous system. Genetic approaches with model organisms continue to identify novel com-
ponents of the pathway, including key molecules that function as positive or negative regulators of Shh sig-
nalling. Data presented here deﬁne Tulp3 as a novel negative regulator of the Shh pathway. We have
identiﬁed a new mouse mutant that is a strongly hypomorphic allele of Tulp3 and which exhibits expansion
of ventral markers in the caudal spinal cord, as well as neural tube defects and preaxial polydactyly, consist-
ent with increased Shh signalling. We demonstrate that Tulp3 acts genetically downstream of Shh and
Smoothened (Smo) in neural tube patterning and exhibits a genetic interaction with Gli3 in limb development.
We show that Tulp3 does not appear to alter expression or processing of Gli3, and we demonstrate that tran-
scriptional regulation of other negative regulators (Rab23, Fkbp8, Thm1, Sufu and PKA) is not affected. We
discuss the possible mechanism of action of Tulp3 in Shh-mediated signalling in light of these new data.
INTRODUCTION
Birth defects remain the greatest cause of infant mortality in the
Western world. These developmental anomalies can affect any
organinthebodyandareoftenseverelydisablingorfatal.Inthe
UK, over 90 000 pregnancies per year (2.3%) are affected by
a major congenital malformation, and amongst the most
common anomalies are defects of the nervous system and
limbs, which are observed in 10 and 16% of affected fetuses,
respectively (1). Reducing the clinical burden from birth
defectsrequiresamorecompleteunderstandingofthecausative
factors, including knowledge of the genetic, cellular and mol-
ecular mechanisms involved, in order to permit the develop-
ment of appropriate preventative therapies. Studies with
model organisms are essential in helping to unravel the
complexnetworkofprocessesinvolvedinnormaldevelopment,
and the identiﬁcation of mutant animals provides key insights
intothepathwaysthatareinvolvedinthesedisorders.Mutagen-
esis of mice with ethylnitrosourea (ENU) has proven to be a
powerful method for the generation of new mutations that
provide good models of human developmental disorders (2–
4). Investigation of these mutants promises to shed new light
on the causes of these defects as well as identifying novel com-
ponents of known signalling pathways.
Development of the mammalian nervous system involves the
initialformationoftheneuraltube,theprecursorofthebrainand
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tissue into spatially appropriate neuronal cell types. The rolling
up and closure of the neural plate to form the neural tube consti-
tutestheprocessofneurulation,andthisoccurswithacharacter-
istic sequence of events and varying neural fold morphology in
different regions of the embryo (5–7). Initiation of neural tube
closure occurs at the level of the cervical/hindbrain boundary
(Closure 1) at E8.5 in mouse, and continues from here both cra-
niallyintothehindbrainandcaudallyalongthedevelopingspine.
Two further sites of closure initiation are observed in the cranial
region, at the forebrain–midbrain boundary (Closure 2) and at
the most rostral extent of the forebrain (Closure 3). Neurulation
in the head is completed with closure of the interveningregions,
termedtheanteriorneuroporeandhindbrainneuropore,byE9.5.
Neural tube closure continues until E10.5 in a cranio-caudal
direction from the site of Closure 1 along the developing spine.
The region immediately caudal to the closed neural tube, in
which the neural folds are elevating and about to close, is
termed the posterior neuropore (PNP). The morphology of the
neural folds within the PNP varies along the spinal axis, and
thishasledtothecharacterizationofthreemodesofspinalneur-
ulation (6). In mode 1 (E8.5–E9), the neural plate exhibits pro-
nounced bending at the ventral midline, the median hinge point
(MHP), but straight lateral folds, whereas in mode 2 (E9–
E9.75) the neural folds bend both at the MHP and also at
paired dorso-lateral hinge points (DLHPs). Closure of the
upper sacral level involves mode 3 neurulation (E9.75–E10.5),
in which the neural plate bends solely at the DLHPs.
The Sonic hedgehog (Shh) signalling pathway is essential for
the normal growth and patterning of many organs including the
nervous system and limbs (8,9). Disruption of Shh signalling
results in a range of congenital defects, including holoprosence-
phaly, craniofacial abnormalities and skeletal malformations
(8,9). Conversely, inappropriate activation of the pathway leads
to neural tube defects, polydactyly, basal cell carcinomas and
tumours of the central nervous system (7,10,11). Shh plays a
key role in regulating closure of the neural tube since Shh
expression in the notochord is necessary and sufﬁcient to
inhibit formation of DLHPs, through a mechanism involving
antagonism of Bmp signalling (12,13). Shh signalling from the
notochord and, subsequently, the ﬂoor plate is also important
for correct dorso-ventral (DV) patterning of the nervous system
(14–18). The spatially restricted speciﬁcation of neuronal sub-
types isessential forthesubsequent assemblyof functional neur-
onal circuits. High concentrations of Shh induce ﬂoor plate
markers, whereas lower concentrations specify increasingly
more dorsal interneuron subtypes within the ventral neural tube.
Absence of Shh signalling results in loss of ventral markers and
complete dorsalization of the spinal cord, whereas ectopic Shh
signalling leads to expansion of ventral markers at the expense
of more dorsal marker domains. Patterning along the anterior–
posterior (AP) axis of the limb is also dependent on the Shh
pathway (19–21). Shh is expressed in the zone of polarizing
activity (ZPA) in the posterior domain of the limb buds, and the
spatial and temporal gradients of Shh activity across the limb
determine digit number and identity. Increased or ectopic Shh
activity leads to polydactyly, whereas decreased Shh activity
results in narrowed limbs and reduced number of digits.
The vertebrate Shh pathway shares fundamental similarities
with that of Drosophila (22–24). Hh ligand binds to Patched
(Ptch) receptor, releasing the repressive activity of Ptch on
Smoothened (Smo) and, thereby, allowing Smo to initiate
intracellular signalling. Downstream of Smo the signal culmi-
nates with the activation of the Ci/Gli transcriptional activa-
tors and removal of the Ci/Gli repressors. Vertebrates
express three Gli family members, Gli1–3; Gli1 functions as
a transcriptional activator, whereas Gli2 and Gli3 can act
both as transcriptional activators and, following proteolytic
removal of the C-terminal region, as transcriptional repressors.
The relative importance of the Gli activator and repressor
forms differs in the patterning of the neural tube and limb.
Neural tube patterning is mostly dependent on ventral Gli1
and Gli2 activators, with less important roles of Gli3 repressor
dorsally (15,25–29). In contrast, limb patterning is generated
predominantly by Gli3, with opposing gradients of Gli3 acti-
vator and Gli3 repressor (30–32). Although vertebate and
Drosophila hedgehog pathways are grossly similar, the inter-
mediate steps between the release of Smoothened and the acti-
vation or processing of Ci/Gli are distinct between species
and, indeed, are not yet fully understood (9,22,33,34).
Forward genetic screens in mouse have successfully ident-
iﬁed additional components of the vertebrate Shh pathway,
with the advantage of no prior bias on the type of molecule
that may be involved (35,36). A number of positive regulators
of Shh signalling have recently been discovered, based on loss
of ventral cell types in the neural tube, including proteins
involved in the formation/maintenance of the primary cilia
or intraﬂagellar transport (37). Several Shh pathway com-
ponents localize within these subcellular organelles (38–42),
and the general consensus is that some aspects of vertebrate
Smo-mediated Gli processing occur within cilia. Speciﬁc pro-
teins have been revealed as negative regulators of the pathway,
since disruption of their function leads to activation of Shh
signalling, as observed by the expansion of ventral marker
domains within the neural tube. The known negative regula-
tors include Ptch1, Sufu, protein kinase A (PKA), Rab23,
Fkbp8 and Thm1 (42–51). PKA phosphorylates Gli3 prior
to processing by the ubiquitin-proteasome pathway (52),
whereas Sufu inhibits the transcriptional activity of Gli activa-
tors in the nucleus and may also sequester Gli in the cytoplasm
(49,50,53,54). Thm1 is involved in intraﬂagellar transport
(42). The functions of Rab23 and Fkbp8 are not clear,
although they may have roles in vesicular trafﬁcking
(55,56). Clearly, the vertebrate Shh pathway is complex, and
our incomplete understanding of the processing and regulation
of intermediate steps suggests that additional components
remain to be discovered.
Here, we report a new ENU-induced mouse mutant that we
have named hitchhiker (hhkr), which exhibits a range of devel-
opmental abnormalities including neural tube defects and
polydactyly. We reveal that hitchhiker carries a strongly hypo-
morphic mutation in Tulp3, and we show that mutants have
ventralization of the caudal spinal cord. We demonstrate that
Tulp3 functions genetically downstream of Shh and Smo,t o
give activation of Shh pathway targets in the absence of Shh
and Smo; complementary results are reported in an accompa-
nying paper (Norman et al., submitted for publication). In
addition, we show that the hitchhiker mutant exhibits a
genetic interaction with Gli3 in limb development, but does
not substantially affect Gli3 processing or expression.
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tive regulators (Rab23, Fkbp8, Thm1, Sufu and PKA) is not
affected in hitchhiker mutants. We propose that Tulp3 func-
tions as a novel negative regulator of the Shh pathway and
we discuss the possible mechanism of action of Tulp3 in
Shh-mediated signalling in light of these new data.
RESULTS
hitchhiker is a novel mutant with defects in neural tube
and limb development
hitchhiker (hhkr) arose during an on-going screen for recessive
ENU-induced mutations that affect the morphology of mid-
gestation embryos. The mutant was initially identiﬁed
through the presence of neural tube defects, with exencephaly
and/or lumbosacral spina biﬁda aperta, and mutants also com-
monly exhibited oedema (Fig. 1A–D). Histological sections
revealed abnormal morphology of the lower spinal neural
tube in mutants in which the neural tube had closed, with an
expanded lumen and reduced thickness of the neuroepithe-
lium, particularly in the ventral half of the spinal cord
(Fig. 1F, compare with E). Mutants also demonstrated
oedema in the surrounding tissue, and small, dorsally mis-
placed dorsal root ganglia (Fig. 1F). Sections through other
mutants demonstrated the widely splayed neural folds charac-
teristic of spina biﬁda (Fig. 1G). Some hitchhiker fetuses
exhibited a closed thoracolumbar neural tube but which was
not enclosed within the bony vertebral column, either with
or without lumbosacral spina biﬁda (Fig. 1I, compare with
H), and this phenotype may be similar to the human defect
of spina biﬁda occulta. Histological sections through E15.5
hitchhiker embryos with this phenotype conﬁrmed the pre-
sence of a closed neural tube, but with a grossly enlarged
spinal canal, a thin dorsal covering of surface ectoderm and
ﬂanked by the widely spaced cartilage primordia of the devel-
oping vertebrae (Fig. 1K, compare with J). Skeletal prep-
arations of E18.5 fetuses with the exposed thoracolumbar
neural tube (without spina biﬁda) clearly demonstrated
splayed vertebrae in the thoracolumbar region (Fig. 1M,
compare with L) and also revealed abnormal morphology of
the ribs, commonly with bifurcations (Fig. 1O, compare with
N). Since the ribs, vertebrae and dorsal dermis all derive
from the somites (57), the observation of defects in these
tissues might suggest possible abnormalities in somitic devel-
opment in hitchhiker.
The hitchhiker line was named after a limb defect, in which
the ﬁrst digit exhibited an abnormal backward-bent position
(Fig. 1P and Q). More often, mutants exhibited preaxial poly-
dactyly on both fore- and hindlimbs, with six or occasionally
seven digits (Fig. 1R and S). Skeletal preparations revealed a
spectrum of defects, including apparent bifurcation or dupli-
cation of digit one, or full or partial duplication of another
digit (Fig. 1T–W and data not shown).
The observed phenotypes were all partially penetrant and
occurred in any combination: 68% of fetuses exhibited poly-
dactyly (n ¼ 73;  E12.5); 65%, spina biﬁda aperta; 58%,
oedema; 37%, exencephaly; 8%, spina biﬁda occulta and 5%
no detectable defect (n ¼ 126,  E10.5). Approximately
6% of heterozygotes exhibited a mild head misshaping or
slight caudal oedema.
hitchhiker carries a splice site mutation in Tulp3 causing
a strongly hypomorphic function
Genetic mapping using a genome-wide marker panel and nine
affected individuals revealed linkage of hitchhiker to Chromo-
some 6 (Fig. 2A), and analysis with additional markers and
individuals reﬁned the interval to 12 Mb (Fig. 2B). Within
this region lies Tulp3; since a targeted allele of Tulp3 exhibits
neural tube defects similar to hitchhiker (58), we examined
Tulp3 in our mutant. RT–PCR analysis revealed a reduced
size for one Tulp3 amplicon (Fig. 2C), and sequencing
revealed a deletion of 52 bp corresponding precisely to exon
2 (data not shown). Genomic DNA analysis identiﬁed a
single nucleotide substitution at the highly invariant position
2 of the splice donor site immediately 3’ to exon 2 (Fig. 2D
and E) (59).
Deletion of exon 2 creates a frameshift that is predicted to
cause premature truncation of the protein (Fig. 2F) and a
null phenotype. Western blots conﬁrmed a dramatic reduction
in Tulp3 protein in hitchhiker homozygotes, although long
exposures detected Tulp3 at 4% of the wild-type level
(Fig. 2G and H), suggesting that hitchhiker is a strong hypo-
morph of Tulp3 rather than a complete null. Tulp3 protein
was reduced to 60% wild-type level in heterozygotes
(Fig. 2G and H). To further verify that Tulp3 mutation is
responsible for the hitchhiker phenotype, we intercrossed
hitchhiker heterozygotes with mice heterozygous for the
Tulp3-targeted allele, Tulp3
tm1Jng (58), with both strains on a
C3H background. This yielded embryos exhibiting the range
of phenotypes displayed by either homozygous mutant
(Fig. 2I and J; n ¼ 8), indicating a failure of complementation.
The phenotype of both the targeted allele homozygotes and the
double heterozygous embryos appears to be slightly more
severe than that of hitchhiker homozygotes, with more exten-
sive oedema and defects in eye development. Together, these
data indicate that hitchhiker is a strong hypomorph of Tulp3.
Neural tube defects in hitchhiker result from a failure
of brain and PNP closure
Following identiﬁcation of the mutant gene, we conducted
detailed morphological and histological examination of
mutant embryos during the stages of neurulation in order to
determine the cause of the neural tube defects. In the cranial
region, mutant embryos exhibited normal de novo closure at
the future cervical region (Closure 1) and the rostral extent
of the forebrain (Closure 3) (data not shown). In contrast,
the occurrence of Closure 2, at the forebrain–midbrain bound-
ary, was delayed or failed: 22% of hitchhiker embryos exhib-
ited failure of Closure 2 even at the 24–27 somite stage, while
a further 15% had achieved Closure 2 but retained an open
hindbrain neuropore at this stage, in contrast to the complete
head closure seen in wild-type embryos by the 21 somite
stage (Fig. 3A and B). The exencephalic phenotype observed
in 37% of fetuses at later stages, therefore, corresponds pre-
cisely to the earlier failure of either Closure 2 or hindbrain
neuropore closure.
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closure. From around the 17-somite stage, hitchhiker
mutants exhibited a signiﬁcantly enlarged PNP, compared
with stage-matched wild-type and heterozygous littermates
(Fig. 3C–E). In wild-types and heterozygotes, the PNP
remained open in only 25% of embryos by the 27 somite
stage (n ¼ 4 of 20), whereas 72% of hitchhiker mutants exhib-
ited an open PNP at this stage (n ¼ 13 of 18). These ﬁgures
Figure 1. hitchhiker mutant mouse embryos exhibit defects in neural tube, skeleton and limb development. (A–D) E13.5 wild-type (A) and hitchhiker embryos
(B–D) with a range of phenotypes, including oedema (B), oedema with spina biﬁda (C) and oedema with spina biﬁda and exencephaly (D). Asterisks mark
region with spina biﬁda and exencephalic region is marked with arrowheads. (E–G) Transverse sections stained with haematoxylin and eosin (H&E)
through spinal neural tissue in wild-type (E), mutant with caudal oedema and dorsally positioned dorsal root ganglia (asterisk) (F) and mutant with spina
biﬁda (G). (H and I) Dorsal views of E18.5 wild-type (H) and hitchhiker mutant (I) fetuses demonstrating splayed vertebrae (arrowheads) and visible neural
tube (asterisk) adjacent to a region of open spina biﬁda (arrow) in mutants. (J and K) H&E-stained sections through the thoracolumbar region of E15.5 wild-type
(J) and hitchhiker (K) fetuses. The mutant exhibited the splayed vertebrae phenotype, and sections demonstrate a closed but abnormally shaped neural tube
within a grossly enlarged spinal canal (asterisk), covered dorsally with a thin layer of surface ectoderm (arrow) and ﬂanked by widely spaced vertebral primordia
(arrowheads), compared with wild-type. (L–O) Skeletal preparations of E18.5 wild-type (L and N) and hitchhiker mutant (M and O) fetuses stained with alcian
blue for cartilage and alizarin red for bone, demonstrating splayed vertebrae (M; arrows) and rib bifurcations (O; arrows) in mutants. (P and Q) Forelimbs from
wild-type (P) and hitchhiker mutants (Q) at E13.5, demonstrating malposition of digit 1 in mutants. (R and S) E15.5 wild-type (R) and hitchhiker (S) limb buds
showing preaxial polydactyly with six digits. (T–W) E16.5 skeletal preparations for wild-type forelimb (T) and hitchhiker mutants (U–W) demonstrating pre-
axial polydactyly with a range of phenotypes. Limbs are oriented with anterior to right. Scale bars: A–D and H: 2.5 mm; E–G: 0.5 mm; H and I: 5 mm; J and K:
1 mm; L–O: 4 mm; P and Q: 1 mm; R and S: 1.1 mm; T–W: 1.2 mm.
1722 Human Molecular Genetics, 2009, Vol. 18, No. 10correspond closely to the spina biﬁda observed in later
embryos, both in the incidence (65%) and the region affected;
at later stages, hitchhiker embryos exhibited an open neural
tube corresponding to the region between somites 24 and 34.
More caudally, the spinal neural tube appeared normal,
suggesting that secondary neurulation proceeds unhindered
Figure 2. hitchhiker carries a splice site mutation in Tulp3 resulting in severely reduced protein expression and function. (A) Genome-wide scan with 55 SNP
markers on nine affected fetuses, showing percentage of mice typing as homozygous C57BL/6 at each marker; hitchhiker shows linkage to Chromosome 6. (B)
Genetic map following analysis with 67 affected fetuses; numbers on left indicate genetic separation of markers (in centimorgan). hitchhiker maps to 12 Mb
(5 cM) region between SNP120 and D6Mit219, a region containing Tulp3.( C) Gel of RT–PCR products of Tulp3 ampliﬁed between exons 1 and 3, from
wild-type, homozygous and heterozygous mutants, showing reduced amplicon size in hhkr.( D) Sequence trace from genomic DNA revealed single nucleotide
substitution, T in wild-type to A in hhkr (circled). (E) Comparison with consensus splice sequence (59) reveals hhkr mutation occurs in the splice junction
immediately 3’ to exon 2. Uppercase: exon, lowercase: intronic sequence, bold: invariant. (F) Schematic representation of Tulp3 protein in wild-type and pre-
dicted truncation following exon 2 deletion in hitchhiker.( G) Western blot analysis on total cell lysates from whole E9.5 embryos demonstrating reduced Tulp3
protein in heterozygous embryos and almost complete absence in homozygous mutant embryos, relative to wild-type littermates. (H) Quantitation of Tulp3
expression in heterozygous and mutant embryos, normalized to b-tubulin, shown as a percentage of wild-type; n ¼ 3 blots, E9.5 or E11.5 whole embryos. (I
and J) Complementation test between hitchhiker and the Tulp3-targeted allele, Tulp3
tm1Jmg (58) generated double-mutant embryos with exencephaly, spina
biﬁda and oedema, E12.5. Scale bar: I and J: 2.5 mm.
Human Molecular Genetics, 2009, Vol. 18, No. 10 1723in hitchhiker. Thus, in the spinal region as in the cranial
region, we have demonstrated that neural tube defects occur
as a primary defect in neural tube closure.
Previous detailed analysis of spinal neural tube closure has
documented three ‘modes’ of closure, characterized by the
precise morphology of the neural folds (6). Histological sec-
tions through the PNP revealed abnormal morphology in
hitchhiker embryos. At the 24 somite stage, wild-type and het-
erozygous embryos exhibited prominent DLHPs, character-
istic of mode 2 neurulation (Fig. 3F–H). In contrast,
Figure 3. Exencephaly and spina biﬁda in hitchhiker result from a failure of neural tube closure. (A and B) Proportion of embryos demonstrating completely
closed cranial neural tube (black bar), initiation of head closure at Closure 2 with open hindbrain neuropore (dark grey) or open cranial region with failure of
Closure 2 (light grey), within the somite ranges marked, in wild-type (A) and hitchhiker (B) embryos. Number of embryos within each group is shown at the top
of each column. (C) Length of PNP in wild-type, heterozygote and hitchhiker mutant embryos, at 22–24 somite stage, in millimetre; mean+SEM. (D and E)
Lateral view of E9.5 (20 somite) wild-type (D) and hitchhiker (E) embryos demonstrating enlarged PNP in mutants; anterior limit of PNP is marked with arrows.
(F–K) Transverse H&E-stained sections through the caudal end of 24 somite wild-type (F–H) and hitchhiker (I–K) embryos, within the PNP (F, G, I and J), or
closed neural tube (H). Wild-type embryos exhibit Mode 2 neurulation with clear DLHPs (asterisks), whereas hitchhiker embryos have reduced DLHPs that are
apparent only adjacent to the closed neural tube (K, asterisk). (L and M) Immunostaining for phosphorylated histone H3 to examine cell proliferation in the
caudal neuroepithelium of E9.5 wild-type (L) and hitchhiker (M) embryos. Red; phosphorylated histone H3; blue, DAPI. (N) Quantitative analysis of cell pro-
liferation in the neuroepithelium, displayed as percentage of cells stained for phosphorylated histone H3, revealing no signiﬁcant difference in percentage pro-
liferation in hitchhiker caudal ends. Scale bar: D and E: 1 mm; F–M: 100 mm.
1724 Human Molecular Genetics, 2009, Vol. 18, No. 10hitchhiker mutants exhibited a reduction in this dorso-lateral
bending, with small DLHP seen only in the sections immedi-
ately adjacent to the closed neural tube and straight neural
folds observed more caudally (Fig. 3I–K). The rates of cell
proliferation and cell death in the neuroepithelium of the
caudal neural tube at E9.5 were not signiﬁcantly different
between hitchhiker mutants and wild-type littermates
(Fig. 3L–N and data not shown). These results suggest that
the abnormal neural fold morphology may be causative for
the delay in PNP closure in hitchhiker mutants.
hitchhiker mutants exhibit increased Shh pathway activity
during spinal neural tube closure
To investigate the cause of the neuroepithelial defects, we
examined the expression of Shh, a key molecule involved
in the regulation of neural tube closure. Strong expression
of Shh in the notochord represses DLHP formation during
mode 1 neurulation, whereas weaker Shh activity during
mode 2 neurulation permits DLHPs to form (13). By whole
mount in situ hybridization, Shh expression appeared compar-
able between hitchhiker mutants and wild-type embryos at
E9.5 (Fig. 4A and B), and transverse sections through the
caudal region revealed similar intensities of expression in
the notochord (Fig. 4C and D). At this stage and axial
level, Shh expression is not yet induced in the wild-type
ﬂoor plate, and Shh is similarly absent from the hitchhiker
ﬂoor plate (Fig. 4C and D). To investigate the activity of
the Shh pathway, as opposed to the expression of Shh
ligand, we examined the expression of the transcriptional
target of Shh signalling, Ptch1. Whole mount in situ hybrid-
ization revealed a dramatic up-regulation of Ptch1 expression
in the caudal region of the neural tube in hitchhiker mutants
(Fig. 4E and F). Transverse sections through these embryos
demonstrated an expanded domain of Ptch1 expression
throughout the DV extent of the caudal neural tube in hitch-
hiker, compared with wild-type (Fig. 4G and H). Quantitative
analysis by real-time RT–PCR (qRT–PCR) detected a
1.65-fold increase in Ptch1 expression in the caudal third
of E9.5 embryos, compared with wild-type (Supplementary
Material, Fig. S1A). In addition, a similar qRT–PCR analysis
of Gli1, another transcriptional target of the Shh pathway,
detected a 1.5-fold increase in Gli1 expression in hitchhiker
(Supplementary Material, Fig. S1B; P , 0.05). These data
suggest that the activity of the Shh pathway is increased in
hitchhiker mutants, at E9.5, independently of a change in
Shh expression. We suggest that this may inhibit the for-
mation of DLHPs.
Further analysis at E10.5 revealed continued overexpres-
sion of Ptch1 in hitchhiker mutants, compared with wild-type
littermates. At this stage as at E9.5, the most dramatic
up-regulation of Ptch1 expression was observed in the
caudal neural tube, but ectopic expression was also evident
in the caudal somites (Fig. 4I–L). Although Shh expression
looked normal at E9.5, by E10.5 Shh is ectopically expressed
in hitchhiker mutants, in approximately one-third of the
spinal cord anterior to the hindlimb bud (Fig. 4M and N;
asterisks). Transverse sections through the lumbar neural
tube demonstrated a dramatic increase in the Shh expression
domain. Shh expression extends throughout the ventral half of
the neural tube in hitchhiker mutants, whereas it is restricted
to the ﬂoor plate in wild-type embryos (Fig. 4O and P). The
spatial and temporal relationship between the onset of Ptch1
and Shh overexpression suggest that in hitchhiker mutants,
activation of the Shh pathway occurs independently of
increased Shh ligand, which then subsequently (and
indirectly) induces the ectopic expression of Shh within the
neural tube.
hitchhiker mutants exhibit ventralization
of the caudal spinal cord
Activity of the Shh pathway is a key regulator of DV pattern-
ing within the neural tube, and the observed changes in Ptch1
and Shh expression in hitchhiker mutants prompted us to
examine the expression of markers of DV patterning at
E10.5. As anticipated from the expansion of Shh mRNA
expression, we detected dorsal expansion of both Shh and
Foxa2 protein expression, markers of ﬂoor plate, in the
lumbar neural tube of hitchhiker mutants (Fig. 5A–D),
although the region that exhibits the columnar morphology
characteristic of ﬂoor plate appears to be unaltered. In
addition, Nkx2.2, which marks the progenitors of the V3
ventral interneurons adjacent to the ﬂoor plate, and Nkx6.1,
and Olig2 which mark other ventral and ventro-lateral
neurons, are all expanded dorsally in hitchhiker mutant
embryos (Fig. 5E–J). HB9/MNR2 and Islet1/2, markers of dif-
ferentiating motorneurons, were also ectopically expressed in
dorsally extended domains in hitchhiker mutants (Fig. 5K–
N). Correspondingly, markers of dorso-lateral and dorsal
neurons, Pax6, Pax7 and Msx, exhibited smaller expression
domains in hitchhiker mutants, with a dorsal shift in their
ventral limit of expression (Fig. 5O–T). Patterning of the
neural tube at more cranial spinal levels was largely unaf-
fected in hitchhiker mutants (Supplementary Material,
Fig. S2). Thus, our data reveal ventralization of the caudal
neural tube in hitchhiker mutants, consistent with Tulp3
acting as a negative regulator of the Shh pathway.
Genetic analysis reveals Shh pathway activation in
hitchhiker occurs independently of Shh ligand
The expression changes observed at E9.5 suggested that
up-regulation of the Shh pathway in hitchhiker mutants
occurs independently of a change in Shh expression. We
hypothesized that mutation of Tulp3 leads to loss of repression
of the Shh pathway, downstream of Shh ligand. To test this
genetically, we intercrossed hitchhiker with the Shh-targeted
null allele (60). Doubly heterozygous (Shh/þ;hhkr/þ) mice
were viable and fertile, and intercrosses yielded E10.5
embryos with the expected Mendelian ratio of genotypes.
Although hhkr homozygotes often exhibited exencephaly
and caudal oedema (Fig. 6B), Shh null mutants were character-
ized by holoprosencephaly and reduced growth (Fig. 6C,
compare with A), as described previously (60). Compound
homozygous Shh/Shh;hhkr/hhkr embryos exhibited exence-
phaly, caudal oedema and spina biﬁda (Fig. 6D). These pheno-
types are characteristic of hitchhiker and distinct from those of
the Shh null, demonstrating that hitchhiker is epistatic to Shh.
Human Molecular Genetics, 2009, Vol. 18, No. 10 1725To investigate this further, we assessed the DV patterning in
the caudal neural tube of double mutant embryos. Immunos-
taining on transverse sections through the caudal spinal cord
of Shh mutants revealed a dorsalized phenotype, distinct
from both the wild-type expression pattern (Fig. 6E–H) and
ventralized phenotype of hhkr embryos (Fig. 6I–L). In Shh
mutants, Nkx2.2, Nkx6.1, Olig2, HB9 and Islet1 are absent
while Pax6, Pax7 and Msx are expanded ventrally
(Fig. 6M–P and data not shown), as reported previously
(45). In the Shh/Shh;hhkr/hhkr double mutants, Nkx2.2,
Nkx6.1, Olig2, HB9 and Islet1 were expressed throughout a
dorsally extended domain in double mutants, in a pattern
similar to hhkr (Fig. 6Q–S and data not shown). The ventral
limits of Pax6, Pax7 and Msx expression domains were
shifted dorsally (Fig. 6T and data not shown), similar to hitch-
hiker. Thus, doubly homozygous Shh/Shh;hhkr/hhkr embryos
revealed ventralization of the neural tube similar to that in
hitchhiker mutants, and dissimilar to the dorsalization seen
in Shh mutants. In addition, analysis of Ptch1 and Gli1
expression demonstrated increased expression in Shh/
Shh;hhkr/hhkr embryos, similar to that observed in hhkr (Sup-
plementary Material, Fig. S3), and in striking contrast to the
absence of Ptch1 expression in Shh mutant embryos. These
data further support our conclusion that Tulp3 acts down-
stream of Shh, and indicates that mutation of Tulp3 leads to
activation of Shh pathway targets in the absence of Shh ligand.
hitchhiker is genetically epistatic to Smoothened
Since the hedgehog pathway can be activated by ligands other
than Shh, we sought to test whether the pathway activation
observed in hitchhiker mutants could be caused by increased
expression of another ligand, such as Indian hedgehog or
Desert hedgehog. Immunostaining with the 5E1 antibody
that was raised against Shh (61), but which detects all hedge-
hog ligands (62), detected no observable signal in the noto-
chord, neural tube or adjacent tissue of Shh/Shh;hhkr/hhkr
double mutants, suggesting this is not the case (Fig. 7B,
compare with A). For a more formal test, we intercrossed
hitchhiker with the Smo-targeted null allele (63) to test for
dependence on Smoothened, an obligate component of all
hedgehog signalling. Doubly heterozygous (Smo/þ;hhkr/þ)
mice were viable and fertile, and intercrosses yielded E10.5
embryos with the expected Mendelian ratios of genotypes.
Smo null mutants were characterized by cyclopia, holoprosen-
cephaly, retarded growth and pericardial oedema (Fig. 7E), as
described previously (63). Compound homozygous Smo/
Smo;hhkr/hhkr fetuses exhibited a phenotype more closely
reminiscent of hhkr homozygotes than Smo null embryos,
with expansion of the caudal spinal cord and a relatively
normal head and growth, although pericardial oedema was
also observed (Fig. 7F, compare with C–E).
Immunostaining on transverse sections through the caudal
spinal cord of doubly homozygous (Smo/Smo;hhkr/hhkr)
embryos revealed ventralization of the neural tube similar to
that seen in hitchhiker mutant embryos, and distinct to the dor-
salized phenotype observed in Smo mutants (Fig. 7O–R).
Nkx2.2 and Islet1 were expressed throughout a dorsally
extended domain (Fig. 7S and T), whereas the ventral limits
of Pax6, Pax7 and Msx expression domains were shifted dor-
sally (Fig. 7U and V and data not shown), similar to hitchhiker
(Fig. 7K–N). These data reveal that Tulp3 acts downstream of
Smo, and indicates that mutation of Tulp3 leads to activation
of the Shh pathway independently of Smo receptor.
Figure 4. hitchhiker mutants exhibit increased Ptch1 expression prior to
increased Shh expression. E9.5 (A–H) and E10.5 (I–P) embryos following
wholemount in situ hybridization with riboprobes for Shh (A–D and M–P)
or Ptch1 (E–L). (A–D) At E9.5, Shh expression is comparable in wild-type
(A) and hitchhiker (B) embryos, and transverse sections reveal expression is
conﬁned to the notochord (C and D). (E–H) Ptch1 expression at E9.5 is
increased in hitchhiker mutants (F) compared with wild-type (E), in the
caudal half of the embryo. Transverse sections demonstrate up-regulated
and expanded expression in the caudal neural tube of mutant (H) compared
with wild-type (G). (I–L) At E10.5, Ptch1 expression remains greatly
enhanced at the caudal end of hitchhiker embryos (J and L) compared with
wild-type (I and K). (M–P) At E10.5, ectopic Shh expression is evident in
hitchhiker embryos along approximately one-third of the spinal cord, anterior
to the hindlimb (N, asterisks, compare with M). Transverse sections reveal
greatly expanded Shh expression domain within the caudal neural tube of
hitchhiker (P) compared with wild-type (O). Scale bars: A, B, E, F, I, J, M
and N: 1 mm; C, D, G, H, K, L, O, P: 100 mm.
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Shh signalling and a genetic interaction with Shh and Gli3
The hitchhiker mutants exhibit preaxial polydactyly, and we
hypothesized that this might be caused by ectopic activation
of the Shh pathway, similar to that observed in the neural
tube. To address this, we examined the expression of targets
of the Shh pathway in the developing limb buds. Shh
expression appeared normal in hitchhiker limb buds, with a
single domain of expression in the ZPA at E11.0 (Fig. 8A).
In contrast, ectopic expression of Ptch1 was observed in the
anterior region of mutant limb buds at E11.0, whereas
expression appeared normal in the posterior region
(Fig. 8B). We also observed ectopic expression of Gli1 in
the anterior domain (Fig. 8C), although this was less robust
than for Ptch1, and Hoxd13 (Fig. 8D) another target of Shh
pathway activation. Thus, hitchhiker mutants show normal
expression patterns of markers in the posterior region of the
limb buds but appear to have ectopic activation of Shh
pathway targets in the anterior region of the limb, in the
absence of ectopic Shh ligand.
To determine whether Tulp3 acts downstream of Shh in the
limb (as well as in the neural tube), we examined limb mor-
phology in Shh/Shh;hhkr/hhkr double mutants. Although
hitchhiker mutants exhibited preaxial polydactyly with six
digits on both forelimbs and hindlimbs (Fig. 9B, compare
with A), Shh mutants are characterized by shortened and nar-
rowed limbs bearing only a single digit (Fig. 9C), as described
previously (64). The Shh/Shh;hhkr/hhkr double homozygotes
reproducibly demonstrated an intermediate phenotype, with
two digits on the forelimbs and four digits on hindlimbs
(Fig. 9D). Although the limbs of double homozygotes do not
resemble either single mutant, the mutation of Tulp3 can par-
tially rescue the severe limb defects of Shh mutants, consistent
with Tulp3 acting genetically downstream of Shh.
Figure 5. hitchhiker mutants exhibit ventralization of the caudal spinal cord. Immunostaining of transverse sections through the neural tube immediately anterior
to the hindlimb bud with antibodies against Shh (A and B), Foxa2 (C and D), Nkx2.2 (E and F), Nkx6.1 (G and H), Olig2 (I and J), HB9/MNR2 (K and L),
Islet1 (M and N), Pax6 (O and P), Pax7 (Q and R) and Msx (S and T), in wild-type (A, C, E, G, I, K, M, O, Q and S) and hitchhiker (B, D, F, H, J, L, N, P, R and
T) embryos at E10.5. Ventral and ventro-lateral markers (Shh, Foxa2, Nkx2.2, Nkx6.1, Olig2, HB9/MNR2 and Islet1) exhibit expanded expression domains in
hhkr while dorsal markers (Pax6, Pax7 and Msx) are reduced. Scale bar: 300 mm.
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three Gli-family transcription factors, with Gli3 playing
the major role in limb patterning (30–32). To investigate
the relationship between Gli3 and Tulp3 genetically, we
intercrossed hitchhiker mutants with mice heterozygous
for the Gli3 null allele, Gli3
XtJ (65). Doubly heterozygous
hhkr/þ;Gli3/þ mice were viable and fertile, and inter-
crosses yielded embryos of all the expected genotypes
except for surviving doubly homozygous mutants, at
E15.5. Analysis of digit number in the different genotypic
classes revealed an additive genetic interaction between
hhkr and Gli3 (Table 1). Heterozygous hitchhiker mice
exhibited normal limbs (Fig. 9F, compare with E),
whereas Gli3/þ fetuses exhibited an extra preaxial digit
( F i g .9 G ) .T h ehhkr/þ;Gli3/þ double heterozygotes
appeared almost phenotypically indistinguishable to single
Gli3/þ heterozygotes, with most limbs exhibiting a single
extra digit (Fig. 9H). The hhkr/hhkr single homozygotes
exhibited preaxial polydactlyly with six or seven digits
(Fig. 9I). Introduction of one Gli3 mutant allele onto the
homozygous hhkr/hhkr genotype appears to exacerbate the
hitchhiker phenotype, with more severe polydactyly than
Figure 6. Genetic analysis of epistasis places Tulp3 downstream of Shh. (A–D) E10.5 embryos generated from intercrossing Shh/þ;hhkr/þ doubly heterozy-
gotes, demonstrating phenotypes of wild-type (A), hitchhiker (B), Shh (C) and Shh/Shh;hhkr/hhkr doubly homozygous (D) embryos. Double mutants grossly
resemble hitchhiker.( E–T) Immunostaining of transverse sections through the neural tube immediately anterior to the hindlimb bud with antibodies against
Nkx2.2 (E, I, M and Q), Nkx6.1 (F, J, N and R), HB9/MNR2 (G, K, O and S) and Pax6 (H, L, P and T) in wild-type (E–H), hitchhiker (I–L), Shh (M–P)
and Shh/Shh;hhkr/hhkr doubly homozygous (Q–T) embryos. Immunostaining of double mutants is similar to hitchhiker. Scale bar: A–D: 2.5 mm; E–T:
300 mm.
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erozygotes, with often seven or eight digits (Fig. 9J;
compare with I and G; Table 1). Homozygous Gli3/Gli3
embryos exhibited severe polysyndactyly with often seven
to nine digits (Fig. 9K), as described previously (65). Intro-
duction of one hhkr mutant allele onto the Gli3/Gli3 geno-
type (hhkr/þ;Gli3/Gli3) appears to make no difference to
the limb defect, which is almost indistinguishable to that
observed in Gli3/Gli3 single mutants, with seven to nine
digits formed (Fig. 9L, compare with K; Table 1). Doubly
homozygous hhkr/hhkr;Gli3/Gli3 embryos did not survive
to E15.5. Attempts to collect embryos at E12.5 yielded
only one double mutant in which limb morphology was
abnormal, but retarded development meant digit number
could not be reliably ascertained. The absence of doubly
homozygous mutant data precludes a formal assessment of
epistasis. However, the analysis of intermediate genotypes
demonstrates that there is a genetic interaction between
the two loci, and suggests that Tulp3 and Gli3 may act in
concert during limb morphogenesis.
Figure 7. Ventralization of the spinal cord in hitchhiker occurs independently of Smo.( A and B) Immunostaining of wild-type and Shh/Shh;hhkr/hhkr double
homozygous embryos with 5E1 antibody to detect all Hedgehog ligands. (C–F) E10.5 embryos generated from intercrossing Smo/þ;hhkr/þ double heterozy-
gotes, demonstrating phenotypes of wild-type (C), hitchhiker (D), Smo (E) and Smo/Smo;hhkr/hhkr doubly homozygous (F) embryos. Double mutants more
closely resemble hitchhiker than Smo.( G–V) Immunostaining of transverse sections through the neural tube immediately anterior to the hindlimb bud with
antibodies against Nkx2.2 (G, K, O and S), Islet1 (H, L, P and T), Pax6 (I, M, Q and U) and Pax7 (J, N, R and V) in wild-type (G–J), hitchhiker (K–N),
Smo (O–R) and Smo/Smo;hhkr/hhkr (S–V) doubly homozygous embryos. Scale bar: A and B: 500 mm, C–F: 2.5 mm; G–V: 300 mm.
Human Molecular Genetics, 2009, Vol. 18, No. 10 1729Gli2 and Gli3 abundance and Gli3 processing appear
unaltered in hitchhiker mutants
Shh pathway activity is mediated by the stimulation of Gli
activators and inhibition of Gli repressors. Since we have
demonstrated that Tulp3 acts genetically downstream of Shh
and Smo, and genetically interacts with Gli3, we sought to
determine whether Gli2 and Gli3 expression are altered in
hitchhiker mutants. By qRT–PCR, the expression of Gli2
and Gli3 was not detectably altered in the caudal end of
E9.5 mutant embryos, compared with wild-type (Fig. 10A).
Other mutants that affect Shh signalling demonstrate dramatic
differences in Gli3 processing, as seen, for example, in the ftm,
IFT88/polaris and Dnchc2 mutants (66–69), prompting us to
look for similar changes in the abundance of the Gli3 isoforms
in hitchhiker mutants. Since the Gli3 Ab we used detects mul-
tiple bands, we performed western blots with protein extracts
from Gli3
XtJ/XtJ mutants, which lack Gli3 protein (65,70), in
order to conﬁrm the correct band identity (Fig. 10B). Exper-
iments with forelimb buds isolated from E9.5 embryos, thus
at a stage before changes in gene expression are apparent,
revealed no observable change in the abundance of either
the full length or cleaved Gli3 isoforms compared with wild-
type or heterozygous littermates (Fig. 10B). In addition, Wes-
terns performed with nuclear extracts from E10.5 embryos
detected no change in the abundance of either full length or
cleaved isoforms, in hitchhiker mutants, suggesting that Gli3
entry into the nucleus is not affected (Fig. 10C). From these
data, we conclude that the action of Tulp3 does not appear
to be mediated through regulation of Gli expression, proces-
sing or nuclear localization, although we cannot rule out the
possibility that small differences might exist that would not
be easily detectable due to experimental variability.
Expression of Rab23, Fkbp8, Thm1 and Sufu, activity of
PKA and morphology of cilia are unaltered in hitchhiker
Since tubby family proteins may function as transcription
factors (71), we hypothesized that Tulp3 might act by regulat-
ing the expression of another negative regulator. By qRT–
PCR, we detected no signiﬁcant change in Rab23, Fkbp8 or
Thm1 (Ttc21b) expression in hitchhiker homozygotes com-
pared with wild-type or heterozygous littermates, in the
caudal thirds of E9.5 embryos, where the phenotype is appar-
ent (Fig. 11A). Western blotting detected no change in Sufu
expression in hitchhiker mutants compared with wild-type
embryos at E9.5 (Fig. 11B). Assays for PKA activity in
protein extracts from the caudal third of E9.5 embryos
detected no signiﬁcant difference in PKA activity between
hitchhiker mutants and wild-types (Fig. 11C). We conclude
that Tulp3 does not regulate the expression of Rab23,
Fkbp8, Thm1 or Sufu, nor the activity of PKA.
Recent evidence indicates that cilia play a major role in Shh
pathway activity. Although most mutants affecting cilial mor-
phology or function lead to a decrease in Shh pathway func-
tion, such as seen in the IFT52, IFT57, IFT88/polaris,
IFT172 and Kif3a mutants (66–69,72,73), at least one
mutant that affects retrograde intraﬂagellar transport results
in activation of the Shh pathway (42). This prompted us to
examine cilial morphology in hitchhiker mutants. Scanning
electron microscopy (SEM) on limb buds from E11.5
embryos revealed the presence of cilia on both wild-type
and hitchhiker mutant cells, with no overt difference in their
length or morphology (Fig. 11D–I). Immunoﬂuorescence
with anti-acetylated tubulin and anti-polaris on cultures of
mouse embryonic ﬁbroblasts or limb bud cells conﬁrmed the
presence of cilia in both hitchhiker mutant and wild-type
cells with no detectable difference in polaris distribution
(Fig. 11J–M and data not shown). Thus, no gross defect in
cilial morphology was observed in hitchhiker homozygotes.
DISCUSSION
In this study, we have identiﬁed a novel ENU-induced strongly
hypomorphic allele of Tulp3 which exhibits ventralization of
the caudal neural tube, neural tube defects and polydactyly.
We demonstrate ectopic expression of Shh pathway targets,
independently of a change in Shh expression, and show
Figure 8. hitchhiker mutants exhibit ectopic expression of Shh pathway
targets in the anterior region of the limb buds. (A–D) Forelimb buds from
E11.0 wild-type (left) or hitchhiker (right) embryos following wholemount
in situ hybridization with riboprobes for Shh (A), Ptch1 (B), Gli1 (C) and
Hoxd13 (D); anterior to right. Shh expression looks similar in wild-type and
mutant limbs, whereas Ptch1, Gli1 and Hoxd13 show normal posterior
expression but a small region of ectopic expression in the anterior domain
(arrows). Scale bar: 1 mm.
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We also demonstrate that Tulp3 genetically interacts with Gli3
in regulating limb morphogenesis, but does not noticeably
affect Gli3 expression or processing. We propose that Tulp3
functions to negatively regulate the Shh pathway in the
caudal neural tube and limb buds.
Tulp3 functions as a negative regulator of Shh signalling
in neural tube and limb
The targeted allele of Tulp3 has previously demonstrated a
requirement for Tulp3 in neural tube closure (58); however,
Tulp3 has not previously been associated with DV patterning
of the neural tube nor with limb defects. In this study, we have
demonstrated that Tulp3 functions as a negative regulator of
the Shh pathway in the developing neural tube and limbs.
This conclusion is based on three sets of experimental
results, which are the established criteria for identifying
novel components of the Shh pathway (45,47,74). First, we
observed increased/ectopic expression of genes activated by
Shh signalling in the hitchhiker mutants, in the caudal spinal
cord and anterior limb domains. Shh is necessary and sufﬁ-
cient for the expression of ventral neural tube cell types
including ﬂoor plate, motor neurons, V2 and V3 interneurons
(60,61,75), and markers of these neurons/progenitors were
expressed in expanded domains in the caudal neural tube of
hitchhiker mutants. Neural tube patterning involves both the
ventralizing signal of Shh from the notochord and ﬂoor
plate, and the dorsalizing signal of BMPs and Wnts from the
roof plate and surface ectoderm, with modulation of patterning
by FGFs and retinoic acid (14–18,76). Although antagonism
of BMP signalling in neural explants leads to a
dorsal-to-ventral switch in the neuronal progenitor cell identity
induced by a set concentration of Shh (77), embryos in which
BMP or Wnt signalling is abrogated exhibit disruption of the
dorsal interneuron cell populations yet no defects in ventral
neuronal patterning (78–80) arguing against a role for Tulp3
in activating BMP or Wnt signalling. Moreover, four of the
overexpressed genes (Foxa2, Nkx2.2, Ptch1 and Gli1) are
direct transcriptional targets of Shh signalling (81,82). Sec-
ondly, genes that are normally repressed by Shh signalling
are shifted dorsally in the hitchhiker neural tube. Thirdly,
analysis of Shh/Shh;hhkr/hhkr and Smo/Smo;hhkr/hhkr
double mutants shows that the activation of Shh target genes
in hitchhiker mutants is independent of both Shh and Smo,
and that substantial rescue of neural tube patterning and
limb development occur in double mutants. Although BMP
and Wnt signals can modulate the cellular response to Shh,
the speciﬁcation of ventral cell fates does not occur in the
absence of hedgehog signalling, even without a ‘repressive’
effect of the dorsalizing signals (77,83). These defects
observed in hitchhiker are established criteria for identifying
negative regulators of the Shh pathway, as used in the charac-
terization of Fkbp8 and Rab23 (45,47).
We have shown that the DV patterning of the neural tube in
Shh/Shh;hhkr/hhkr and Smo/Smo;hhkr/hhkr double mutants is
more closely similar to hitchhiker homozygotes than either
Shh or Smo mutants, indicating that the DV markers are
expressed independently of Shh and Smo. However, the
expression patterns are not identical between double mutants
and hitchhiker homozygotes. Nkx2.2 and Islet1 are expressed
throughout the most ventral (ﬂoor plate) domain in double
mutants, whereas they are excluded from this region in wild-
type and hitchhiker homozygote. Foxa2 is expressed in an
expanded domain in hitchhiker homozygotes, but appears to
be absent from double mutants (Supplementary Material,
Fig. S3). In addition, low-intensity Pax6 expression was
evident throughout the ventral neural tube of Smo/Smo;hhkr/
hhkr mutants, while it is excluded from this region in wild-
types and hitchhiker homozygotes. These results indicate
that the activation of Foxa2 expression and the repression of
Nkx2.2, Islet1 and Pax6 from the ventral domains remain
Figure 9. Genetic analysis shows hitchhiker acts downstream of Shh and interacts with Gli3 in limb development. (A–D) E12.5 embryos generated from inter-
crossing Shh/þ;hhkr/þ double heterozygotes, demonstrating phenotypes of the forelimbs (FL) and hindlimbs (HL) of wild-type (A), hitchhiker (B), Shh (C) and
Shh/Shh;hhkr/hhkr double mutant fetuses (D); anterior to right. (E–L) FL and HL of E15.5 embryos generated from intercrossing hhkr/þ;Gli3/þ double hetero-
zygotes; positioned with anterior to the right. Wild-type (E) and hhkr/þ (F) embryos have normal limbs with ﬁve digits; Gli3/þ (G) and hhkr/þ;Gli3/þ (H)
display six digits with a small additional preaxial digit; hhkr/hhkr (I) demonstrates six or seven digits; hhkr/hhkr;Gli3/þ (J) exhibits seven digits; Gli3/Gli3 (K)
has polysyndactyly with seven or eight digits, plus an extra postaxial nubin; hhkr/þ;Gli3/Gli3 (L) exhibits polysyndactyly with seven or eight digits, plus an
extra postaxial nubin. Scale bar: 1 mm.
Human Molecular Genetics, 2009, Vol. 18, No. 10 1731dependent on functional Shh and Smo activity. Foxa2 induc-
tion and Nkx2.2, Islet1 and Pax6 repression require very
high levels of Shh activity (84–86), suggesting that down-
regulation of Tulp3 in hitchhiker mutants is not sufﬁcient to
induce high-level activation of the pathway. A similar situ-
ation seems to occur in the developing limbs, whereby the
intermediate phenotype of double mutants suggests that, in
the absence of Shh, mutation of Tulp3 is not sufﬁcient to
induce full activation of the Shh pathway. Intriguingly,
Shh2/2;Gli3þ/þ mice typically form limbs with two to
four digits (31), similar to the phenotype observed in Shh/
Shh;hhkr/hhkr double homozygotes. Although Tulp3 mutation
can lead to activation of some markers in a Shh-independent
manner, the level of Shh pathway activation does not reach
the highest levels that normally occur and, therefore, some
residual Shh-dependent patterning remains.
Some regulators of Shh activity are also transcriptional
targets of the Shh pathway. By western blotting, we found
no substantial change in the abundance of Tulp3 protein in
Shh, Smo or Gli3 mutants (data not shown), suggesting that
Tulp3 is not itself a transcriptional target of the Shh
pathway. Involvement of Tulp3 as a negative regulator of
the Shh pathway suggests that down-regulation of Tulp3
activity might be required for Shh signalling. Tulp3 has
several putative sites for phosphorylation, myristoylation and
glycosylation (87). It is possible that regulation of Tulp3
activity might occur through effects on post-translational
modiﬁcation.
Possible functions of Tulp3 in the Shh pathway
The tubby family consists of four proteins, Tubby and
Tulps1–3, which are characterized by the C-terminal ‘tubby’
domain (88,89). Disruption of other tubby proteins has been
associated with a range of phenotypes, including retinal and
cochlear degeneration following progressive cell apoptotis,
and maturity-onset obesity (90–94). No tubby member has
previously been linked to Shh signalling.
We have demonstrated that hitchhiker mutants exhibit a
phenotype consistent with Tulp3 acting as a negative regulator
of Shh signalling, and we have positioned Tulp3 genetically
downstream of Shh and Smo. Many regulators of the Shh
pathway have recently been discovered, and several have
been shown to act genetically downstream of Shh and Smo.
These include proteins involved in the formation or mainten-
ance of cilia and intraﬂagellar transport, such as Arl13b/
hennin, IFT88/polaris/ﬂexo, IFT172/wimple, Kif3a, Rpgrip1l/
Fantom and Thm1 (38,42,66,68,69,72,95). Disruption of IFT
or cilia usually results in reduced Shh pathway activity in
the neural tube, evidenced by the absence of Shh-dependent
ventral cell types, as seen in mutants for IFT88/polaris/ﬂexo,
IFT172/wimple, Kif3a, Rpgrip1l/Fantom, Dync2h1/Dnchc2,
IFT52/Ngd5, IFT57/hippi and Ofd1 (67,68,72,96,97).
However, mutation of Arl13b/hennin results in constitutive
activation of the Shh pathway at an intermediate level (95),
whereas loss of Thm1 causes increased Shh activity and
expansion of ventral markers (42). The Gli-mediated transcrip-
tional response to Shh and the effects of the negative regula-
tors Sufu and PKA are abrogated in cells mutant for IFT
components (98). The negative regulators Rab23 and Fkbp8
function genetically between Shh/Smo and Gli2
(45,47,99,100), and their activity is dependent on functional
IFT (66,100). Rab23 is a member of the Rab-GTPase family
of vesicular transport proteins and may regulate vesicular
transport within (or dependent on) cilia, although the targets
of Rab23 trafﬁcking have not been identiﬁed (55,99,101).
Fkbp8 is a member of the FK506-binding protein family
(immunophilins), and may also play a role in membrane-
associated proteasome function and trafﬁcking (56,102).
The importance of cilia is further underlined by the ﬁnding
that several Shh pathway components are localized within the
cilia, including Smo, Ptch, Sufu and Gli proteins (38–
41,67,98). Smo becomes enriched in cilia following treatment
of cells with Shh (39,40,98), and this ciliary localization is
necessary (39) but not sufﬁcient (98) for pathway activation.
Tulp3 protein can be detected at the tips of cilia (37), and evi-
dence from other members of the tubby family suggests that
Tulp3 might play a role in vesicular trafﬁcking. Tulp1 inter-
acts with several proteins implicated in the formation and
movement of vesicles including F-actin, dynamin-1, clathrin
heavy chain, dynein intermediate chain and tubulin
(103,104). Tulp1 mutants exhibit accumulation of rhodopsin-
containing vesicles in the interphotoreceptor matrix, consistent
with loss of polarized trafﬁcking between photoreceptor seg-
ments (91,105). However, examination of cilial morphology
in hitchhiker mutants has detected no overt cilial defect,
whereas immunoﬂuorescence studies revealed no apparent
difference in localization of polaris/IFT88. Thus, there is no
evidence to suggest that cilial morphology or transport is
grossly disrupted in hitchhiker mutants, although more
subtle structural or functional defects would not have been
detected.
An alternative hypothesis for the role of Tulp3 is as a tran-
scriptional regulator. The tubby proteins are characterized by
the C-terminal ‘tubby’ domain that binds to double-stranded
DNA, while the N-terminal region can function as a
Table 1. Genetic interaction between hitchhiker and Gli3, determined by analysis of digit number
hhkr genotype þ/þþ /þþ /þ hhkr/þ hhkr/þ hhkr/þ hhkr/hhkr hhkr/hhkr
Gli3 genotype þ/þ Gli3/þ Gli3/Gli3 þ/þ Gli3/þ Gli3/Gli3 þ/þ Gli3/þ
Number of fetuses examined 10 10 5 21 24 7 7 9
Average number of digits 20.0 24.0 28.8 20.0 24.2 29.0 23.9 27.0
Percentage of limbs with no extra digits 100 0 0 100 0 0 14 0
Percentage of limbs with one extra digit 0 100 20 0 96 14 75 36
Percentage of limbs with two extra digits 0 0 45 0 2 50 11 53
Percentage of limbs with three extra digits 0 0 25 0 2 32 0 11
Percentage of limbs with four extra digits 0 0 10 0 0 4 0 0
1732 Human Molecular Genetics, 2009, Vol. 18, No. 10Figure 10. Gli2 and Gli3 expression and Gli3 processing are not altered in
hitchhiker mutants. (A) Quantitative RT–PCR analysis with primers for
Gli2 and Gli3 on RNA from caudal ends of E9.5 wild-type, heterozygous
and hitchhiker mutant embryos, showing no change in expression. (B)
Western blot analysis on total cell lysates from E9.5 limb buds demonstrate
no apparent change in abundance of the full length 190 kDa Gli3 isoform
(Gli3FL) nor the 83 kDa cleaved repressor isoform (Gli3R), in hitchhiker
embryos compared with wild-type or heterozygous littermates. Western
blots with extracts from Gli3/þ and Gli3/Gli3 mutants conﬁrm correct Gli3
band identify. b-Tubulin was used as a loading control. (C) Western blots
with nuclear extracts from E10.5 caudal ends demonstrate similar abundance
of the 190 and 83 kDa Gli3 isoforms in hitchhiker embryos compared with
wild-type or heterozygous littermates; histone H1 was used as a loading
control.
Figure 11. Evaluation of changes in downstream molecules and cilia structure.
(A) Quantitative RT–PCR analysis with primers for Fkbp8, Rab23 and Thm1
(Ttc21b) on RNA from caudal ends of E9.5 wild-type, heterozygous and hitch-
hiker mutant embryos, showing no signiﬁcant change in expression. (B)
Western blot analysis on total cell lysates from E10.5 limb buds for Sufu
expression revealed no change in hitchhiker mutants; fatty acid synthase (Fas)
was usedasa loadingcontrol.(C)PKAactivitywithorwithoutcAMPaddition,
in protein extracts from E9.5 caudal ends of wild-type and hitchhiker embryos;
no signiﬁcant difference is detected. (D–I) SEM of E11.5 forelimb buds from
wild-type (D–F) and hitchhiker mutant (G–I) embryos revealing cilia of
normal length and morphology. (J–M) Immunostaining of MEFs from wild-
type (J and K) and hitchhiker embryos (L and M) with anti-acetylated tubulin
(green),anti-polaris(red)antibodiesandDAPI(blue)demonstratesimilarstain-
ing in mutants and wild-type cilia. Scale bars: 2 mm.
Human Molecular Genetics, 2009, Vol. 18, No. 10 1733transcriptional activator (71). The tubby proteins also encode
nuclear localization signals and can be detected in the cell
nucleus (87,93,106). Experiments suggest tubby proteins trans-
locate from the plasma membrane into the nucleus in response
to Gaq-coupled receptor signalling (107). The phenotype of
hitchhiker mutants might be consistent with transcriptional
down-regulation of another negative regulator of the Shh
pathway. Indeed, it is striking that hitchhiker bears many simi-
larities with the Rab23
opb mutant, including gross phenotypic
effects (exencephaly, dorsal expansion of the caudal spine,
small and dorsally misplaced dorsal root ganglia, polydactyly,
rib bifurcations and splayed vertebrae) (108,109), similar pat-
terning defects in the caudal neural tube (45,99,110) and posi-
tioning genetically downstream of Shh and Smo (45,99). The
disruption of Fkbp8 or partial loss of function of PKA
(Pka-plof) also yield partial ventralization of the neural tube,
similar to that seen in hitchhiker (46,47,100). However, we
have shown that expression of Rab23, Fkbp8, Thm1, Gli3 and
SufuandactivityofPKAarenotdetectablyalteredinhitchhiker
mutants. Thus, although we cannot rule out a transcriptional
role for Tulp3 on some other yet undiscovered negative regula-
tor, we have excluded transcriptional modulation of the known
negative modulators of Shh signalling.
Modulation of Gli protein activity is the downstream conse-
quence of the Shh pathway, since the presence of Shh ligand
acts to inhibit cleavage of Gli3 (30) and suppress the proces-
sing and degradation of Gli2 (111). Many mutants that
exhibit down-regulation of the Shh pathway show impaired
Gli3 processing, with a decrease in the amount of Gli3 repres-
sor relative to the amount of full-length Gli3 protein, as seen in
mutants for Dync2h1/Dnchc2, IFT88/polaris, IFT172/wimple,
Kif3a, Rpgrip1l/fantom and the chicken talpid
3 mutant
(38,67–69,72,73,112). Gli3 processing is also disrupted in
the Thm1 mutant, which has activation of Shh signalling
(42). The negative regulator Sufu binds to the Gli proteins
(113,114) and may act in part by sequestering Gli1 and Gli2
in the cytoplasm (49,53,114,115), a function that involves
CRM1-dependent nuclear export of Gli1 but not Gli2 (54).
We have shown that Tulp3 genetically interacts with Gli3 in
regulating limb development. However, we observed no
change in the expression levels of Gli2 or Gli3, and we
detected no substantial change in the abundance of the Gli3
isoforms in hitchhiker. This suggests that Tulp3 function is
not associated with Gli expression or processing. In addition,
we observed no alteration in abundance of Gli3 within the
nucleus, suggesting that Tulp3 does not act to regulate entry
into the nucleus.
It is possible that Tulp3 may function as a co-factor in Gli
activity or may affect the interaction of Gli with other regula-
tors. Sufu can inhibit the transcriptional activator function of
Gli1 and Gli2, independently of cytoplasmic sequestration
(54). Sufu mutant MEFs exhibit constitutive Gli activity yet
do not show accumulation of Gli1 in the nucleus (50). Sufu
interacts with SAP18, Galectin3 and other nuclear proteins
(116) as well as with Gli1 bound to DNA (53), and Sufu
represses Gli-mediated transcription by recruiting the histone
deacetylation machinery through interaction with SAP18
(117). Although we detected no change in Sufu expression
level, it is possible that loss of Tulp3 might affect the inter-
action of Sufu with Gli; recent data have revealed that
Cdc2l1 can act as a pathway activator, through binding to
Sufu and relieving its inhibition on Gli (118). Alternatively,
Tulp3 might act to regulate the expression or activity of
other factors that regulate Gli protein function, such as
MED12 (119), MIM/BEG4 (120), CBP (81), Ski (121),
Dyrk1 (122), DYRK2 or MAP3K10 (123). The precise func-
tional and molecular relationship between Gli3 and Tulp3
requires further analysis.
It is intriguing that the hitchhiker limb buds exhibit a loca-
lized domain of ectopic gene expression, at the anterior limit
of the limb buds. This is distinct from the ectopic expression
patterns observed in other mutants, in which there is an
anterior expansion of the normal expression domains. Many
other mutants with polydactyly have impaired processing of
Gli3, and this may cause the limb defect. It is possible that
Tulp3 acts in regulation of speciﬁc targets of Gli3 function,
which then subsequently results in the region-speciﬁc acti-
vation of other molecules. Microarray analysis of transcrip-
tional changes in Gli3 mutant limb buds identiﬁed a number
of targets, including some that are expressed in localized
anterior domains and which are down-regulated in Gli3
mutants; these include Pax9, Cdo and Id2 and novel transcript
BG074838 (124). We might hypothesize that Tulp3 has a role
in co-regulation of speciﬁc Gli3 targets, resulting in loss of an
anterior-speciﬁc factor, rather than a general change in Gli3
effects in the limb.
hitchhiker mutants exhibit spina biﬁda as a result
of a failure of neural tube closure
We have demonstrated that spina biﬁda in hitchhiker results
from a primary failure of spinal neural tube closure. Closure
of the PNP occurs with three ‘modes’ of closure, at different
gestational ages and, therefore, at different axial levels, typi-
ﬁed by the formation of MHPs (mode 1), DLHPs (mode 3)
or both (mode 2) (6). The regulation of DLHP formation is
modulated by Shh expression, with strong Shh expression
from the notochord during mode 1 neurulation inhibiting
DLHPs (12), through the noggin-mediated antagonism of
Bmp signalling (13). Formation of DLHPs is critical for
spinal closure, and failure to form DLHPs results in severe
spina biﬁda as seen in the Zic2 mutant (13). In hitchhiker
mutants, the formation of DLHPs appears to be partially sup-
pressed, although they are not inhibited completely, and corre-
spondingly, the spina biﬁda in hitchhiker is less severe than
observed in Zic2 mutants. We have demonstrated increased
activation of the Shh pathway at the caudal end of hitchhiker
mutants, and this would be anticipated to repress DLHP for-
mation. Indeed, the loss of other negative regulators of the
Shh pathway can also result in spina biﬁda, including Sufu,
Rab23, PKA and Ptch1 (45,46,48,109). However, we also
observed defects in DV patterning of the neuroepithelium at
E9.5 (data not shown). It is likely that PNP closure is inhibited
by a combination of these effects.
Regional differences in the role of Tulp3
Our data reveal a role for Tulp3 in DV patterning of the neural
tube, with a more important role in caudal than cranial regions
of the spinal cord. Tulp3 is expressed ubiquitously (58),
1734 Human Molecular Genetics, 2009, Vol. 18, No. 10suggesting that the AP difference is not attributable to differ-
ential expression. It is notable that the role of other molecules
in DV patterning also varies along the AP axis. For example,
mutation of Rab23, Fkbp8 or PKA-deﬁciency affect only
caudal spinal cord patterning (45–47,110), whereas the
Dync2h1/Dnchc2 mutant exhibits a more severe patterning
disruption in rostral than caudal regions of the spinal cord
(72) and retinoic acid modulates patterning in the rostral
spinal cord of quail embryos (125). Smo2/2;Gli32/2
embryos show reduced rescue of the ventral markers more
caudally, and this is taken to indicate an AP difference in
the requirement for Hh/Gli3 interactions in the speciﬁcation
of similar cell identities (75). The molecular basis of the
regional differences and the relationship between the
pathway regulators has yet to be fully elucidated.
The data presented here led to similar conclusions as a study
performed with the Tulp3-targeted allele (Norman et al., sub-
mitted). However, there are minor variations between the phe-
notypes, such as the absence of Foxa2 expression in the Shh/
Shh;hhkr/hhkr double mutant, compared with expression of
this ﬂoor plate marker in double mutants with the Tulp3 null
allele, and no signiﬁcant change in proliferation in the
caudal neural tube of hitchhiker, compared with decreased
proliferation in the Tulp3 knockout. These qualitative differ-
ences likely reﬂect the difference in abundance of Tulp3
protein, in the two alleles, since the targeted allele is likely
to be a true null, while we have demonstrated in hitchhiker
that a small amount (4%) of wild-type protein remains.
In conclusion, correct regulation of the activity of the Shh
pathway is essential for normal development and continued
health in adults. Misregulation during embryonic development
generates a spectrum of congenital abnormalities, including
holoprosencephaly, neural tube defects and polydactyly. The
continued identiﬁcation of new components of the Shh
pathway, such as Tulp3, coupled with further research to
understand their molecular function, holds signiﬁcant
promise for the diagnosis and treatment of human disease.
MATERIALS AND METHODS
Mice and embryos
hitchhiker was identiﬁed during a three-generation (G3) reces-
sive mutagenesis screen (details to be described elsewhere).
Brieﬂy, C57BL/6 males were injected with ENU and out-
crossed to C3H/HeH; male F1 offspring were mated to C3H/
HeH and F2 females backcrossed to their father. G3
embryos were examined at E13.5 for developmental abnorm-
alities. Affected fetuses were used for genetic mapping with a
55-marker genome-wide SNP panel (sequences available on
request), and additional microsatellite markers. The mutant
line was maintained by backcrossing to C3H/HeH and, follow-
ing gene identiﬁcation, genotyped for the mutation by
pyrosequencing. The MGI accession ID for this allele is
MGI:3662473. Mice heterozygous for Shh
tm1Chg (60) or
Smo
tm1Amc (63) were maintained on 129S6/SvEv and geno-
typed by PCR (N. Warr, personal communication). Mice het-
erozygous for the Tulp3
tm1Jng-targeted allele (58) on C3Heb/
FeJ were obtained from J. Eggenschwiler (Princeton Univer-
sity). Mice heterozygous for Gli3 deletion (Gli3
XtJ/þ)o na
mixed C57BL/6/C3H background were obtained from
T. Theil (Edinburgh University) and genotyped as described
(126). Animals were maintained following guidelines of the
Medical Research Council and in accordance with the
Animals (Scientiﬁc Procedures) Act, 1986.
Mice were maintained routinely on a 12 h light–dark cycle
(dark from 19:00 to 07:00 h). Embryos were generated by
overnight matings, with the day of ﬁnding a copulation plug
designated as embryonic day (E) 0.5. Some mice were main-
tained on a reverse light–dark cycle (dark from 10:00 to
22:00 h), and litters from these animals were designated as
E1.0 on the day of plugging. Embryos were dissected in
PBS with 10% newborn calf serum and processed according
to downstream application.
Sequencing
RNA was extracted from E13.5 fetuses using GenElute
(Sigma) and reverse transcribed with MMLV-RT (Invitrogen).
DNA and cDNA were ampliﬁed with intron or exon-speciﬁc
Tulp3 primers (sequences available on request), puriﬁed
using Qiaquick (Qiagen) then sequenced with BigDye
reagent (ABI) and ABI3700.
Histology and in situ hybridization
Histology and skeletal preparations used standard protocols.
Wholemount in situ hybridization was performed essentially
as described (127), using digoxigenin-labelled riboprobes for
Shh, Ptch1, Gli1, and Hoxd13. At least three embryos of
each genotype were analysed with each probe and processed
under identical conditions. Embryos were photographed on a
Leica MZ16 stereomicroscope and vibratome sectioned at
35–50 mm as described (128). Slide in situ hybridization
was performed using 10 mm cryosections as described else-
where (129), with digoxigenin-labelled riboprobes for Ptch1
and Gli1.
Protein extraction, western blots and PKA assay
Total cell lysates were generated in RIPA buffer (PBS with
1% Nonidet P40, 0.5% sodium deoxycholate, 0.1% SDS).
Nuclear fractions were generated using the Proteoextract Sub-
cellular Fractionation kit (Calbiochem). Proteins were quanti-
tated using the DC assay (Biorad). Westerns used 1–5 mg
protein per lane on 7% or 3–8% Tris-Acetate NuPAGE gels
with SeeBluePlus2 or HiMark ladders (Invitrogen). Proteins
were transferred onto Hybond ECL (GE Healthcare) and
detected with antibodies against Tulp3 (1:300; gift from
J. Eggenschwiler), Gli3 (1:1000; Santa Cruz sc-20688), Sufu
(1:200; sc-10933), b-tubulin (1:5000; sc9104), histone H1
(1:1000, sc-8030) or fatty acid synthase (1:1000; sc-55580)
with HRP-conjugated secondary antibodies (1:12000;
DAKO) and detection with ECL Advance (GE Healthcare).
Extracts from Gli3
XtJ/XtJ (65) and Sufu2/2 (50) mutants
were used to verify Gli3 and Sufu band identity, respectively,
and the antibodies used have been published previously
(70,130). Bands were quantitated from scanned images using
Adobe Photoshop CS2; data are expressed as means + stan-
dard errors, and signiﬁcance tested using two-sample equal
Human Molecular Genetics, 2009, Vol. 18, No. 10 1735variance, two-tailed distribution Student’s t-test. PKA activity
was measured on extracts from E9.5 caudal thirds using a non-
radioactive assay (Calbiochem), following Bradford assay
quantitation.
SEM, cell culture and immunoﬂuorescence
Embryos were processed for SEM as described (38) and
imaged on an Hitachi S-530 scanning electron microscope.
Mouse embryonic ﬁbroblast primary cultures were immunos-
tained for N-acetylated tubulin (1:10000; Sigma) or Polaris
(1:1000; gift from B. Yoder) as described (38). Immunoﬂuor-
escence on 10 mm cryosections was performed as described
(131), using antibodies against Nkx2.2, Shh, Islet1, Msx1/2,
Foxa2, HB9/MNR2, Nkx6.1, Pax6 and Pax7 (1:10; Develop-
mental Studies Hybridoma Bank) and Olig2 (1:500, Abcam
ab33427). Cell proliferation rates were determined by staining
with antibody against phospho-Histone H3 (pHH3, Upstate
Cell Signalling). Primary antibody staining was detected
with appropriate secondary antibodies conjugated with
AlexaFluor-488 or AlexaFluor-594 (1:250 dilution; Invitro-
gen), mounted in Vectashield with DAPI (Vector Labora-
tories) and imaged with a Zeiss Axiophot microscope.
Quantitation of proliferation rates was performed by counting
pHH3þ cells and total (DAPIþ) cells within the caudal neu-
roepithelium of E9.5 (17–19 somite) embryos; the mitotic
index was calculated as the average from 12 sections from
each of six embryos of each genotype, with analysis from
the region immediately posterior to the caudal extremity of




with a Nanodrop ND1000 and theintegrityassessed by gel elec-




w gene expression assays on a 7500 Fast
Real-Time PCR System (Applied Biosystems). The assays
used were: Mm00494645_m1 (Gli1); Mm00487418_m1
(Fkbp8); Mm01293116_m1 (Gli2); Mm00492333_m1 (Gli3);
Mm01545399_m1 (Hprt); Mm00436209 (Rab23);
Mm00436026 (Ptch1) and Mm01270405 (Ttc21b). Samples
were analysed in quadruplicate, using at least three embryos of
each genotype, and calculations performed using the compara-
tive CT method. The values were normalized to the endogenous
reference gene (Hprt) and the transcript levels are presented as
fold change relative to the wild-type sample in relative quantiﬁ-
cation (RQ) units. Error bars indicate the calculated maximum
(RQMax) and minimum (RQMin) expression levels, with a 95%
conﬁdence level. Statistical signiﬁcance was tested using two-
sample equal variance, two-tailed distribution Student’s t-test
and is also represented as non-overlapping error bars if the
samples are signiﬁcantly different (P , 0.05).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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